Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients
Source: American Journal of Hematology - Category: Hematology Authors: John C. Reneau, Dennis Asante, Holly Van Houten, Lindsey R. Sangaralingham, Francis K. Buadi, Amir Lerman, Joerg Herrmann Tags: Correspondence Source Type: research